Statistics for Vigil Neuroscience, (id:8132 VIGL)
Valuation metrics
Market cap
136.54M
Enterprise value
77.79M
Trailing P/E (ttm)
-1.50
Forward P/E
-1.84
PEG ratio
-1.84
Price/Sales (ttm)
Price/Book (mrq)
1.03
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.87
Overview
Shares outstanding
39.65M
Float
20.96M
Shares short
513.30K
% Held by insiders
0.21%
% Held by institutions
0.80%
Average volume (10 days)
51.26K
Average volume (90 days)
Price summary
52-Week low
2.47
52-Week high
6.06
52-Week change
-3.76%
Beta
1.93
50-Day moving average
3.58
200-Day moving average
3.48
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-39.66%
Return on equity
-70.12%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-89,622,000.00
Net income to common (ttm)
-83,836,000.00
Diluted EPS (ttm)
-2.11
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
86.67M
Total cash per share (mrq)
2.19
Total debt (mrq)
13.41M
Total Debt/Equity (mrq)
15.72
Current ratio (mrq)
838.80%
Book value per share (mrq)
3.24
Cash flow
Cash flow statement
-70,207,000.00
Levered free cash flow (LFCF)
-41,546,376.00